Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: A new strategic phase for genomic medicine in UK health services | Genome Medicine Commentary A new strategic phase for genomic medicine in UK health services Hilary Burton Caroline F Wright and Ron Zimmern Address PHG Foundation 2 Worts Causeway Cambridge CB1 8RN UK. Correspondence Hilary Burton. Email Abstract In June 2009 the Science and Technology Committee of the UK House of Lords published a report on genomic medicine based on expert evidence collected over an 18-month period. Crucially the report signaled that the use of genomic medicine was at a crossroads due to the rapid development of new technologies and opened up opportunities across the whole of medicine and healthcare. This commentary responds to the report s call for a new health service strategy including a new genetics White Paper from the Government and suggests some of the important elements that need further consideration. Introduction In July 2009 the Science and Technology Committee of the House of Lords part of the UK Parliament published a report on genomic medicine representing an analysis of the many scientific clinical commercial and regulatory issues arising from the rapid expansion in knowledge about the human genome and how it functions 1 . The report is aimed primarily at the UK government but also seeks to influence policy in the UK National Health Service NHS industry the professions research organizations and wider society. Its recommendations around translation integration of genomics into health services and the need for continuing widespread public engagement and debate will have resonance far outside the UK. The pace of change the report argues requires a new strategic phase for genomics in health services. We appraise here elements of such a strategy that will be critical if the promise of improved population health is to be realized. The inquiry took a wide view of genomic science and medicine and its report concentrated on the emerging use of genetics and genomics within medicine and how this should be .
